Logo image of CMBTO.OL

CMB TECH NV (CMBTO.OL) Stock Fundamental Analysis

OSL:CMBTO - BE0003816338 - Common Stock

94.4 NOK
+3.4 (+3.74%)
Last: 9/8/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, CMBTO scores 4 out of 10 in our fundamental rating. CMBTO was compared to 63 industry peers in the Oil, Gas & Consumable Fuels industry. While CMBTO belongs to the best of the industry regarding profitability, there are concerns on its financial health. CMBTO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CMBTO had positive earnings in the past year.
In the past year CMBTO had a positive cash flow from operations.
CMBTO had positive earnings in 4 of the past 5 years.
Of the past 5 years CMBTO 4 years had a positive operating cash flow.
CMBTO.OL Yearly Net Income VS EBIT VS OCF VS FCFCMBTO.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

CMBTO has a Return On Assets of 12.31%. This is amongst the best in the industry. CMBTO outperforms 93.65% of its industry peers.
CMBTO has a better Return On Equity (79.11%) than 98.41% of its industry peers.
CMBTO's Return On Invested Capital of 5.20% is in line compared to the rest of the industry. CMBTO outperforms 41.27% of its industry peers.
CMBTO had an Average Return On Invested Capital over the past 3 years of 9.19%. This is in line with the industry average of 9.83%.
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROIC 5.2%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.19%
ROIC(5y)N/A
CMBTO.OL Yearly ROA, ROE, ROICCMBTO.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

CMBTO's Profit Margin of 72.50% is amongst the best of the industry. CMBTO outperforms 98.41% of its industry peers.
CMBTO's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 35.88%, CMBTO is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
In the last couple of years the Operating Margin of CMBTO has grown nicely.
CMBTO has a better Gross Margin (58.65%) than 69.84% of its industry peers.
In the last couple of years the Gross Margin of CMBTO has remained more or less at the same level.
Industry RankSector Rank
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBTO.OL Yearly Profit, Operating, Gross MarginsCMBTO.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CMBTO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CMBTO has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CMBTO has less shares outstanding
The debt/assets ratio for CMBTO is higher compared to a year ago.
CMBTO.OL Yearly Shares OutstandingCMBTO.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBTO.OL Yearly Total Debt VS Total AssetsCMBTO.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CMBTO has an Altman-Z score of 0.74. This is a bad value and indicates that CMBTO is not financially healthy and even has some risk of bankruptcy.
CMBTO has a worse Altman-Z score (0.74) than 77.78% of its industry peers.
CMBTO has a Debt/Equity ratio of 3.75. This is a high value indicating a heavy dependency on external financing.
CMBTO's Debt to Equity ratio of 3.75 is on the low side compared to the rest of the industry. CMBTO is outperformed by 92.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Altman-Z 0.74
ROIC/WACC0.68
WACC7.67%
CMBTO.OL Yearly LT Debt VS Equity VS FCFCMBTO.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CMBTO has a Current Ratio of 0.77. This is a bad value and indicates that CMBTO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.77, CMBTO is doing worse than 87.30% of the companies in the same industry.
A Quick Ratio of 0.70 indicates that CMBTO may have some problems paying its short term obligations.
CMBTO has a worse Quick ratio (0.70) than 87.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
CMBTO.OL Yearly Current Assets VS Current LiabilitesCMBTO.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

CMBTO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -99.67%.
The Earnings Per Share has been growing by 43.41% on average over the past years. This is a very strong growth
Looking at the last year, CMBTO shows a very negative growth in Revenue. The Revenue has decreased by -23.87% in the last year.
The Revenue has been growing slightly by 0.55% on average over the past years.
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
Revenue 1Y (TTM)-23.87%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-21.24%

3.2 Future

The Earnings Per Share is expected to decrease by -39.46% on average over the next years. This is quite bad
Based on estimates for the next years, CMBTO will show a very strong growth in Revenue. The Revenue will grow by 26.36% on average per year.
EPS Next Y-68.44%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
EPS Next 5YN/A
Revenue Next Year35.16%
Revenue Next 2Y30.13%
Revenue Next 3Y26.36%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBTO.OL Yearly Revenue VS EstimatesCMBTO.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CMBTO.OL Yearly EPS VS EstimatesCMBTO.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 472.00, which means the current valuation is very expensive for CMBTO.
CMBTO's Price/Earnings ratio is a bit more expensive when compared to the industry. CMBTO is more expensive than 74.60% of the companies in the same industry.
CMBTO is valuated expensively when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
CMBTO is valuated cheaply with a Price/Forward Earnings ratio of 4.95.
CMBTO's Price/Forward Earnings ratio is rather cheap when compared to the industry. CMBTO is cheaper than 95.24% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.66, CMBTO is valued rather cheaply.
Industry RankSector Rank
PE 472
Fwd PE 4.95
CMBTO.OL Price Earnings VS Forward Price EarningsCMBTO.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

74.60% of the companies in the same industry are cheaper than CMBTO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.86
CMBTO.OL Per share dataCMBTO.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

The decent profitability rating of CMBTO may justify a higher PE ratio.
A cheap valuation may be justified as CMBTO's earnings are expected to decrease with -39.46% in the coming years.
PEG (NY)N/A
PEG (5Y)10.87
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%

0

5. Dividend

5.1 Amount

CMBTO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CMB TECH NV

OSL:CMBTO (9/8/2025, 7:00:00 PM)

94.4

+3.4 (+3.74%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13/bmo
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.83B
Analysts82
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend57.1
Dividend Growth(5Y)116.35%
DP109.72%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.31%
Min EPS beat(2)-149.02%
Max EPS beat(2)-49.61%
EPS beat(4)1
Avg EPS beat(4)9.95%
Min EPS beat(4)-149.02%
Max EPS beat(4)242.1%
EPS beat(8)5
Avg EPS beat(8)86.48%
EPS beat(12)8
Avg EPS beat(12)69.92%
EPS beat(16)10
Avg EPS beat(16)53.9%
Revenue beat(2)1
Avg Revenue beat(2)55.28%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)120.37%
Revenue beat(4)3
Avg Revenue beat(4)60.54%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)125.33%
Revenue beat(8)6
Avg Revenue beat(8)55.68%
Revenue beat(12)10
Avg Revenue beat(12)56.45%
Revenue beat(16)14
Avg Revenue beat(16)57.36%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 472
Fwd PE 4.95
P/S 2.13
P/FCF N/A
P/OCF 11.06
P/B 2.32
P/tB 2.72
EV/EBITDA 11.86
EPS(TTM)0.2
EY0.21%
EPS(NY)19.08
Fwd EY20.22%
FCF(TTM)-29.91
FCFYN/A
OCF(TTM)8.53
OCFY9.04%
SpS44.42
BVpS40.71
TBVpS34.72
PEG (NY)N/A
PEG (5Y)10.87
Profitability
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROCE 6.75%
ROIC 5.2%
ROICexc 5.31%
ROICexgc 5.46%
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.19%
ROIC(5y)N/A
ROICexc(3y)10.15%
ROICexc(5y)N/A
ROICexgc(3y)10.2%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Debt/EBITDA 7.03
Cap/Depr 666.34%
Cap/Sales 86.55%
Interest Coverage 3.85
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z 0.74
F-Score2
WACC7.67%
ROIC/WACC0.68
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
EPS Next Y-68.44%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.87%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-21.24%
Revenue Next Year35.16%
Revenue Next 2Y30.13%
Revenue Next 3Y26.36%
Revenue Next 5YN/A
EBIT growth 1Y-38.91%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-783.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3YN/A
OCF growth 5Y11.04%